* German Q4 GDP grows more than expected
* AstraZeneca to deliver fewer-than-expected vaccines to EU
* Sportswear maker Puma drops as lockdowns affect sales
* Norway's Bakkafrost bottoms out STOXX 600 (Updates to market close)
By Shashank Nayar and Ambar Warrick
Feb 24 (Reuters) - European shares rose on Wednesday as sectors primed to benefit from economic recovery were supported by strong German growth data, although concerns over a possible rise in inflation and lofty equity valuations kept gains in check.
The pan-European STOXX 600 .STOXX ended 0.5% higher, with Germany's DAX .GDAXI adding 0.8% as data showed bullish exports and solid construction activity helped Europe's biggest economy to grow by a stronger-than-expected 0.3% in the fourth quarter. stocks .SXTP jumped 1.9% to near one-year highs, leading European sector gains on optimism around major countries lifting coronavirus-induced lockdowns.
Still, global airline industry body IATA flagged further headwinds for airlines in 2021. market has fallen recently due to lofty valuations, but investors are becoming more accepting of the fact that as European economies slowly reopen and earnings improve, the current equity valuations could be justified," said Chris Beauchamp, chief market analyst at IG Group.
The benchmark STOXX 600 has rebounded nearly 50% from its March 2020 lows, also led by historic stimulus measures, but it has still far underperformed a 75% jump in the U.S. S&P 500 .SPX .
U.S. Federal Reserve Chair Jerome Powell reiterated on Tuesday that interest rates will remain low despite indications of rising inflation, assuaging some fears of a sudden tapering in monetary stimulus. another stimulus package will certainly be welcomed by market participants, inflation fears are still present, despite those concerns being downplayed by officials," said Milan Cutkovic, market analyst at Axi.
"As more countries are planning the reopening of their economies, the focus could slowly shift back to value stocks."
The rotation out growth-driven stocks was apparent, with the technology sector .SX8P losing nearly 4% this week, lagging all of its regional peers.
In company news, AstraZeneca AZN.L dipped 0.2% after it told the European Union that it expects to deliver less than half the COVID-19 vaccines it was contracted to supply in the second quarter. salmon farmer Bakkafrost BAKKA.OL was the biggest percentage loser on the STOXX 600 for a second session after it posted a fourth-quarter loss due to the pandemic. sportswear company Puma PUMG.DE dropped 2.1% after saying it expects a heavy impact on its results from lockdowns through the end of the second quarter. Italia TLIT.MI surged 9.2% after it said profit and sales should stabilise this year.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.